Table 6.
Results of multivariate logistic regression models for differentiating stage IA EC from BELs
Models | Coefficients | Odds ratio | 95% CI | p value |
---|---|---|---|---|
Clinical model | ||||
Age at diagnosis, years | ||||
≤ 50 | Reference | |||
51–64 | 1.412 | 4.106 | 2.269–7.429 | < 0.001 |
≥ 65 | 0.574 | 1.776 | 0.563–5.604 | 0.328 |
Nulliparity | ||||
No | Reference | |||
Yes | 1.433 | 4.191 | 1.066–16.472 | 0.040 |
Long-term Tamoxifen therapy | ||||
No | Reference | |||
Yes | − 1.963 | 0.14 | 0.038–0.524 | 0.003 |
ADC histogram model | ||||
ADC10th | − 3.270 | 0.038 | 0.016–0.092 | < 0.001 |
rMAD | − 0.710 | 0.492 | 0.271–0.893 | 0.020 |
Total energy | 1.025 | 2.788 | 1.416–5.490 | 0.003 |
Skewness | 0.605 | 1.832 | 1.155–2.907 | 0.010 |
Combined model | ||||
ADC-score* | 0.971 | 2.641 | 2.045–3.411 | < 0.001 |
Age at diagnosis, years | ||||
≤ 50 | Reference | |||
51–64 | 0.711 | 2.036 | 0.821–5.046 | 0.125 |
≥ 65 | 1.623 | 5.068 | 0.905–28.383 | 0.065 |
Nulliparity | ||||
No | Reference | |||
Yes | 0.446 | 1.562 | 0.252–9.670 | 0.631 |
Long-term Tamoxifen therapy | ||||
No | Reference | |||
Yes | − 0.846 | 0.429 | 0.061–2.996 | 0.393 |
rMAD, robust mean absolute deviation
*ADC-score = 0.257 + − 3.270 × ADC10th + − 0.710 × rMAD + 1.025 × Total_Energy + 0.605 × Sknewness. All ADC histogram features were standardized by Z-score normalization